Grant: Doctoral Research Award: Canada Graduate Scholarships
University of Toronto
$105,000.00
Modelling Functional Recovery After Spinal Cord Injury Using Human Organoids
EF 2019-20
Résumé
Spinal cord injury (SCI) results in either temporary or permanent paralysis. Given that current therapies are ineffective in reversing paralysis, patients face drastically reduced life-expectancies and endure severe psychological, social and economic burdens. The goal of my project is to restore quality of life in SCI patients by promoting regeneration and functional recovery of their spinal cord.
In mammals, each neuron from the brain communicates with neurons in other parts of the body using long projections called axons. These axons extend down the spinal column to form the spinal cord, ultimately making connections with skin and muscle tissue to coordinate sensory-motor function. Given that fully matured neurons are not able to repair themselves once injured, SCI disrupts information transfer through axons and causes an irreversible damage. In order to promote regeneration of axons, I plan to "trick" damaged neurons into thinking they are still in a growth-like-state using small-molecule drugs.
To test these drugs, I will develop a model of SCI using a "mini-spinal cord" made of human tissue. "Mini-organs", known as human organoids, are tissues generated from embryonic stem cells that resemble human organs, both in morphology and function. As opposed to currently used animal models of SCI, a human organoid model is a far superior representative of human degeneration. After generating spinal cord organoids, I will induce injury to mimic SCI and treat the organoid with various small-molecule drugs. This way, a human spinal cord organoid will make the results of my drug testing far more reliable and speed up the drug discovery process.
By developing a functional human spinal cord organoid and testing various growth-promoting small molecule drugs, my project serves to both promote functional regeneration of the central nervous system and provide a new drug discovery platform for spinal cord diseases.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
416994
Name
Zafar Nadia A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Doctoral Research Awards - A
Projecttitle
Modelling Functional Recovery After Spinal Cord Injury Using Human Organoids
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Axon Regeneration; Central Nervous System; Human Organoid Models; Human Pluripotent Stem Cells; Immunohistochemical Analysis; Intraneuronal Signalling Pathways; Mouse Muscle Tissue Explants; Multi-Electrode Arrays; Singe-Cell Rna Sequencing; Spinal Cord Injury
Abstract
Spinal cord injury (SCI) results in either temporary or permanent paralysis. Given that current therapies are ineffective in reversing paralysis, patients face drastically reduced life-expectancies and endure severe psychological, social and economic burdens. The goal of my project is to restore quality of life in SCI patients by promoting regeneration and functional recovery of their spinal cord.
In mammals, each neuron from the brain communicates with neurons in other parts of the body using long projections called axons. These axons extend down the spinal column to form the spinal cord, ultimately making connections with skin and muscle tissue to coordinate sensory-motor function. Given that fully matured neurons are not able to repair themselves once injured, SCI disrupts information transfer through axons and causes an irreversible damage. In order to promote regeneration of axons, I plan to "trick" damaged neurons into thinking they are still in a growth-like-state using small-molecule drugs.
To test these drugs, I will develop a model of SCI using a "mini-spinal cord" made of human tissue. "Mini-organs", known as human organoids, are tissues generated from embryonic stem cells that resemble human organs, both in morphology and function. As opposed to currently used animal models of SCI, a human organoid model is a far superior representative of human degeneration. After generating spinal cord organoids, I will induce injury to mimic SCI and treat the organoid with various small-molecule drugs. This way, a human spinal cord organoid will make the results of my drug testing far more reliable and speed up the drug discovery process.
By developing a functional human spinal cord organoid and testing various growth-promoting small molecule drugs, my project serves to both promote functional regeneration of the central nervous system and provide a new drug discovery platform for spinal cord diseases.
Competitiondate
201911
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Zafar, Nadia A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~